Patents by Inventor Stephane Poigny

Stephane Poigny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipogenesis inhibitor compounds
    Patent number: 9181189
    Abstract: The present invention relates to Formula (I), wherein—if X=NH, each of R1, R2, R3, R4 represents a hydrogen atom; if X=N, the core is aromatic, and R2, R3 and R4 represent hydrogen atoms, and R1=H, halogen, aryl, heteroaryl, alkenyl or acetylenyl; or R1, R2, R3, R4 are defined such that R1 or R2 or R3 or R4 represents a methyl group, and the three other radicals represent a hydrogen atom.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: November 10, 2015
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Daniel Redoules, Sylvie Daunes-Marion, Stephane Poigny, Marie-Florence Galliano
  • NEW LIPOGENESIS INHIBITOR COMPOUNDS
    Publication number: 20140315950
    Abstract: The present invention relates to Formula (I), wherein—if X=NH, each of R1, R2, R3, R4 represents a hydrogen atom; if X=N, the core is aromatic, and R2, R3 and R4 represent hydrogen atoms, and R1=H, halogen, aryl, heteroaryl, alkenyl or acetylenyl; or R1, R2, R3, R4 are defined such that R1 or R2 or R3 or R4 represents a methyl group, and the three other radicals represent a hydrogen atom.
    Type: Application
    Filed: December 10, 2012
    Publication date: October 23, 2014
    Inventors: Daniel Redoules, Sylvie Daunes-Marion, Stephane Poigny, Marie-Florence Galliano
  • Pyrroloquinoline derivatives and their use as protein kinases inhibitors
    Patent number: 8426437
    Abstract: The present invention relates to inhibitors of protein kinases of formula I: which can be used in the treatment of various diseases, notably cancer, inflammation or disorders of the central nervous system. It also relates to pharmaceutical compositions containing the compounds according to the invention and their use in therapy.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: April 23, 2013
    Assignee: Pierre Fabre Medicament
    Inventors: Hugues Bienayme, Antoine Dumoulin, Serge Grisoni, Bachir Kaloun El, Stephane Poigny, Remi Rabot, Rachid Rahali, Eric Tam, Pascaline Klein, Karim Bedjeguelal, Houcine Rahali
  • Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors
    Publication number: 20090042876
    Abstract: The present invention relates to inhibitors of protein kinases of formula I: which can be used in the treatment of various diseases, notably cancer, inflammation or disorders of the central nervous system. It also relates to pharmaceutical compositions containing the compounds according to the invention and their use in therapy.
    Type: Application
    Filed: June 30, 2006
    Publication date: February 12, 2009
    Applicant: Pierre Fabre Medicament
    Inventors: Hugues Bienayme, Antoine Dumoulin, Serge Grisoni, Bachir Kaloun El, Stephane Poigny, Remi Rabot, Rachid Rahali, Eric Tam, Pascaline Klein, Karim Bedjeguelal, Houcine Rahali